Published in J Rheumatol on February 15, 2008
The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics. Sci Transl Med (2011) 3.80
Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev (2009) 2.83
Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: how study designs can affect placebo factors. Pain (2008) 1.98
Fibromyalgia syndrome module at OMERACT 9: domain construct. J Rheumatol (2009) 1.87
Understanding fibromyalgia: lessons from the broader pain research community. J Pain (2009) 1.73
Ten sessions of adjunctive left prefrontal rTMS significantly reduces fibromyalgia pain: a randomized, controlled pilot study. Pain (2011) 1.53
Developments in the scientific and clinical understanding of fibromyalgia. Arthritis Res Ther (2009) 1.06
Effect and treatment of chronic pain in inflammatory arthritis. Curr Rheumatol Rep (2013) 1.06
Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial. Neurology (2010) 1.05
Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain. J Orthop Traumatol (2009) 1.03
Psychometric properties of a single-item scale to assess sleep quality among individuals with fibromyalgia. Health Qual Life Outcomes (2009) 1.03
[Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. Schmerz (2012) 1.02
Pregabalin in fibromyalgia--responder analysis from individual patient data. BMC Musculoskelet Disord (2010) 0.99
Targeting voltage-gated calcium channels for neuropathic pain management. Neurotherapeutics (2009) 0.94
Milnacipran for the management of fibromyalgia syndrome. J Pain Res (2010) 0.93
Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative. Rheumatology (Oxford) (2012) 0.92
Fatigue in fibromyalgia: a conceptual model informed by patient interviews. BMC Musculoskelet Disord (2010) 0.92
Evaluation of the impact of fibromyalgia on patients' sleep and the content validity of two sleep scales. Health Qual Life Outcomes (2009) 0.92
Toward development of a fibromyalgia responder index and disease activity score: OMERACT module update. J Rheumatol (2011) 0.91
Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial. Ann Rheum Dis (2012) 0.88
A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia. Arthritis Res Ther (2012) 0.87
Beyond pain in fibromyalgia: insights into the symptom of fatigue. Arthritis Res Ther (2013) 0.86
The adverse event profile of pregabalin across different disorders: a meta-analysis. Eur J Clin Pharmacol (2012) 0.86
New treatment options in the management of fibromyalgia: role of pregabalin. Neuropsychiatr Dis Treat (2008) 0.85
Interference with work in fibromyalgia: effect of treatment with pregabalin and relation to pain response. BMC Musculoskelet Disord (2011) 0.84
Fibromyalgia Syndrome in Need of Effective Treatments. J Pharmacol Exp Ther (2015) 0.83
Intersection of chronic pain treatment and opioid analgesic misuse: causes, treatments, and policy strategies. Subst Abuse Rehabil (2011) 0.83
Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain. Ther Adv Drug Saf (2014) 0.82
Trazodone plus pregabalin combination in the treatment of fibromyalgia: a two-phase, 24-week, open-label uncontrolled study. BMC Musculoskelet Disord (2011) 0.81
Working memory impairment in fibromyalgia patients associated with altered frontoparietal memory network. PLoS One (2012) 0.81
A systematic cost-effectiveness analysis of pregabalin in the management of fibromyalgia: an Iranian experience. Arch Med Sci (2013) 0.81
Treatment options and patient perspectives in the management of fibromyalgia: future trends. Neuropsychiatr Dis Treat (2008) 0.81
Identification of therapeutic candidates for chronic lymphocytic leukemia from a library of approved drugs. PLoS One (2013) 0.81
Simplifying Fibromyalgia Assessment: The VASFIQ Brief Symptom Scale. Ther Adv Musculoskelet Dis (2011) 0.81
New and emerging therapeutic agents for the treatment of fibromyalgia: an update. J Pain Res (2010) 0.81
Is pregabalin a safe and effective treatment for patients with fibromyalgia? Nat Clin Pract Rheumatol (2008) 0.80
Interpreting effect sizes and clinical relevance of pharmacological interventions for fibromyalgia. Pain Ther (2013) 0.80
Continuing efficacy of milnacipran following long-term treatment in fibromyalgia: a randomized trial. Arthritis Res Ther (2013) 0.80
Pregabalin in the management of partial epilepsy. Neuropsychiatr Dis Treat (2009) 0.80
Evaluation of the effectiveness of pregabalin in alleviating pain associated with fibromyalgia: using functional magnetic resonance imaging study. PLoS One (2013) 0.80
Preliminary experience using milnacipran in patients with juvenile fibromyalgia: lessons from a clinical trial program. Pediatr Rheumatol Online J (2015) 0.80
Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study. Pediatr Rheumatol Online J (2016) 0.78
Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia. J Pain Res (2014) 0.77
Duloxetine for the treatment of fibromyalgia. Expert Rev Clin Immunol (2010) 0.77
The Hebrew version of the FibroFatigue scale: validation of a questionnaire for assessment of fibromyalgia and chronic fatigue syndrome. Rheumatol Int (2009) 0.77
Comparative efficacy and tolerability of duloxetine, pregabalin, and milnacipran for the treatment of fibromyalgia: a Bayesian network meta-analysis of randomized controlled trials. Rheumatol Int (2016) 0.77
Does pregabalin have neuropsychotropic effects?: a short perspective. Psychiatry Investig (2009) 0.76
Pregabalin for the management of fibromyalgia syndrome. J Pain Res (2010) 0.76
Music as a sleep aid in fibromyalgia. Pain Res Manag (2014) 0.76
Pharmacotherapy for fibromyalgia. Front Pharmacol (2011) 0.76
Update on Treatment Guideline in Fibromyalgia Syndrome with Focus on Pharmacology. Biomedicines (2017) 0.75
Milnacipran combined with pregabalin in fibromyalgia: a randomized, open-label study evaluating the safety and efficacy of adding milnacipran in patients with incomplete response to pregabalin. Ther Adv Musculoskelet Dis (2013) 0.75
Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia. Drug Healthc Patient Saf (2016) 0.75
Pregabalin in treatment-refractory fibromyalgia. Open Rheumatol J (2010) 0.75
Effect of milnacipran on body weight in patients with fibromyalgia. Int J Gen Med (2012) 0.75
Improvement in pain severity category in clinical trials of pregabalin. J Pain Res (2016) 0.75
Effect modification, interaction and mediation: an overview of theoretical insights for clinical investigators. Clin Epidemiol (2017) 0.75
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum (2008) 19.80
The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) (2010) 12.31
Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol (2011) 4.72
An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord (2007) 3.71
Psychometric properties of the Medical Outcomes Study Sleep measure. Sleep Med (2004) 3.15
Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2005) 2.71
Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression. Arthritis Rheum (2004) 2.62
Patient perspectives on the impact of fibromyalgia. Patient Educ Couns (2008) 2.57
Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain (2004) 2.32
A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain (2008) 2.28
Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises. Arthritis Rheum (2008) 2.22
Fibromyalgia syndrome. J Rheumatol (2007) 2.04
Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain (2005) 1.97
Fibromyalgia syndrome module at OMERACT 9: domain construct. J Rheumatol (2009) 1.87
Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial. Curr Med Res Opin (2006) 1.72
Cognitive behavioral therapy for the treatment of juvenile fibromyalgia: a multisite, single-blind, randomized, controlled clinical trial. Arthritis Rheum (2012) 1.68
Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept. J Rheumatol (2006) 1.60
Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry (2003) 1.55
Fibromyalgia syndrome. J Rheumatol (2005) 1.49
Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study. Eur J Pain (2007) 1.49
The science of fibromyalgia. Mayo Clin Proc (2011) 1.47
Interpreting patient-reported outcome results: US FDA guidance and emerging methods. Expert Rev Pharmacoecon Outcomes Res (2011) 1.43
Biosimilars: impact of biologic product life cycle and European experience on the regulatory trajectory in the United States. Clin Ther (2012) 1.32
Effects of co-occurring alcohol abuse on the course of bipolar disorder following a first hospitalization for mania. Arch Gen Psychiatry (2005) 1.31
Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania. Arch Gen Psychiatry (2007) 1.18
Pancytopenia--a clinico haematological study of 200 cases. Indian J Pathol Microbiol (2002) 1.16
CSF versus serum leptin in narcolepsy: is there an effect of hypocretin deficiency? Sleep (2006) 1.15
Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome. Arthritis Res Ther (2008) 1.11
B cell-targeted therapy in autoimmune disease: rationale, mechanisms, and clinical application. J Rheumatol (2008) 1.09
Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder. Curr Med Res Opin (2007) 1.09
Lymphatic filariasis: Aspiration of adult gravid female worm from a soft tissue swelling. J Cytol (2010) 1.08
Estimation of minimum clinically important difference for pain in fibromyalgia. Arthritis Care Res (Hoboken) (2011) 1.05
Retracted Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy. ACS Appl Mater Interfaces (2011) 1.04
Ethnicity and diagnosis in patients with affective disorders. J Clin Psychiatry (2003) 1.04
Measures of fibromyalgia: Fibromyalgia Impact Questionnaire (FIQ), Brief Pain Inventory (BPI), Multidimensional Fatigue Inventory (MFI-20), Medical Outcomes Study (MOS) Sleep Scale, and Multiple Ability Self-Report Questionnaire (MASQ). Arthritis Care Res (Hoboken) (2011) 1.04
Metabolism of the colonic mucosa in patients with inflammatory bowel diseases: an in vitro proton magnetic resonance spectroscopy study. Magn Reson Imaging (2008) 1.03
Quality-of-life issues in psoriasis and psoriatic arthritis: outcome measures and therapies from a dermatological perspective. J Am Acad Dermatol (2006) 1.03
Assessment of therapeutic response of locally advanced breast cancer (LABC) patients undergoing neoadjuvant chemotherapy (NACT) monitored using sequential magnetic resonance spectroscopic imaging (MRSI). NMR Biomed (2010) 1.02
Curcuma oil: reduces early accumulation of oxidative product and is anti-apoptogenic in transient focal ischemia in rat brain. Neurochem Res (2007) 1.01
The effect of anxiety and depression on improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgia. Pain Med (2007) 1.00
Changes in pain coping, catastrophizing, and coping efficacy after cognitive-behavioral therapy in children and adolescents with juvenile fibromyalgia. J Pain (2013) 1.00
Long-term outcomes of adolescents with juvenile-onset fibromyalgia in early adulthood. Pediatrics (2014) 1.00
Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndrome. J Rheumatol (2009) 0.99
Topiramate in the long-term treatment of binge-eating disorder associated with obesity. J Clin Psychiatry (2004) 0.99
Actigraphy-based physical activity monitoring in adolescents with juvenile primary fibromyalgia syndrome. J Pain (2010) 0.98
Effect of creatine monohydrate in improving cellular energetics and muscle strength in ambulatory Duchenne muscular dystrophy patients: a randomized, placebo-controlled 31P MRS study. Magn Reson Imaging (2010) 0.98
Congenital mesoblastic nephroma: a rare pediatric neoplasm. Turk Patoloji Derg (2013) 0.97
Family study of fibromyalgia and affective spectrum disorder. Biol Psychiatry (2004) 0.95
Effect of cholecalciferol and calcium supplementation on muscle strength and energy metabolism in vitamin D-deficient Asian Indians: a randomized, controlled trial. Clin Endocrinol (Oxf) (2010) 0.94
Rapamycin protects against middle cerebral artery occlusion induced focal cerebral ischemia in rats. Behav Brain Res (2011) 0.93
Development of responder definitions for fibromyalgia clinical trials. Arthritis Rheum (2012) 0.93
Pregabalin in the treatment of refractory neuropathic pain: results of a 15-month open-label trial. Pain Med (2008) 0.92
Assessment of changes in brain metabolites in Indian patients with type-2 diabetes mellitus using proton magnetic resonance spectroscopy. BMC Res Notes (2014) 0.91
Neuroprotective efficacy and therapeutic window of curcuma oil: in rat embolic stroke model. BMC Complement Altern Med (2008) 0.91
Toward development of a fibromyalgia responder index and disease activity score: OMERACT module update. J Rheumatol (2011) 0.91
Improving the routine management of rheumatoid arthritis: the value of tight control. J Rheumatol (2010) 0.90
The transport of non-surfactant based paclitaxel loaded magnetic nanoparticles across the blood brain barrier in a rat model. Biomaterials (2012) 0.89
Influence of patient race and ethnicity on clinical assessment in patients with affective disorders. Arch Gen Psychiatry (2012) 0.88
Early improvement in pain predicts pain response at endpoint in patients with fibromyalgia. J Pain (2011) 0.88
Evaluation of Withania somnifera in a middle cerebral artery occlusion model of stroke in rats. Clin Exp Pharmacol Physiol (2003) 0.87
Cellular interaction of folic acid conjugated superparamagnetic iron oxide nanoparticles and its use as contrast agent for targeted magnetic imaging of tumor cells. Int J Nanomedicine (2012) 0.87
Relationship between school absenteeism and depressive symptoms among adolescents with juvenile fibromyalgia. J Pediatr Psychol (2010) 0.87
Time to onset of neuropathic pain reduction: A retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia. Am J Ther (2010) 0.87
Rapunzel Syndrome Causing Appendicitis in an 8-year-old Girl. Int J Trichology (2012) 0.86
Assessment of sleep in patients with fibromyalgia: qualitative development of the fibromyalgia sleep diary. Health Qual Life Outcomes (2014) 0.85
Elevated serum high-sensitivity C-reactive protein levels in fibromyalgia syndrome patients correlate with body mass index, interleukin-6, interleukin-8, erythrocyte sedimentation rate. Rheumatol Int (2012) 0.85
Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia. Semin Arthritis Rheum (2009) 0.84
Evaluation of folate conjugated pegylated thermosensitive magnetic nanocomposites for tumor imaging and therapy. Colloids Surf B Biointerfaces (2010) 0.83
The fibromyalgia family study: a genome-wide linkage scan study. Arthritis Rheum (2013) 0.83
Evaluation of skin tumors by magnetic resonance imaging. Lab Invest (2003) 0.82
The meaning of pain relief in a clinical trial. J Pain (2005) 0.82
Potential of magnetic resonance spectroscopy to detect metastasis in axillary lymph nodes in breast cancer. Magn Reson Imaging (2005) 0.81
Metabolite profile of cerebrospinal fluid in patients with spina bifida: a proton magnetic resonance spectroscopy study. Spine (Phila Pa 1976) (2005) 0.80
Safety, tolerability and pharmacokinetics of the histamine H3 receptor antagonist, ABT-288, in healthy young adults and elderly volunteers. Br J Clin Pharmacol (2013) 0.80
Genetic polymorphisms of the beta2-adrenergic receptor relate to guanosine protein-coupled stimulator receptor dysfunction in fibromyalgia syndrome. J Rheumatol (2011) 0.80
Squamous predominant teratoid Wilms' tumor. J Lab Physicians (2012) 0.79
Neurochemicals measured by (1)H-MR spectroscopy: putative vulnerability biomarkers for obsessive compulsive disorder. MAGMA (2013) 0.79
Association of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status with total choline concentration and tumor volume in breast cancer patients: an MRI and in vivo proton MRS study. Magn Reson Med (2011) 0.79
The effect of duloxetine treatment on cognition in patients with fibromyalgia. Psychosom Med (2012) 0.79